The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination

Human Molecular Genetics

Volumn 21, Issue 3, 2012, Pages 559-568

  Hahn, Michael A ^a   Dickson, Kristie Ann ^a   Jackson, Stuart ^a   Clarkson, Adele ^b   Gill, Anthony J ^b   Marsh, Deborah J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 73; GLUTAMINE; HETERODIMER; HISTONE H2B; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; RING FINGER PROTEIN; RNF20 PROTEIN; RNF40 PROTEIN; THREONINE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENIC ACTIVITY; CELL METABOLISM; CONTROLLED STUDY; CYTOSKELETON; DNA REPAIR; DOWN REGULATION; EMBRYO; GENE MUTATION; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; OXIDATION REDUCTION REACTION; PARATHYROID TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; YEAST;

HEK293 CELLS; HISTONES; HUMANS; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84856107676     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr490     Document Type: Article

References (43)

1. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science, 293, 1074-1080.
2. Minsky, N., Shema, E., Field, Y., Schuster, M., Segal, E. and Oren, M. (2008) Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat. Cell Biol., 10, 483-488.
3. Moyal, L., Lerenthal, Y., Gana-Weisz, M., Mass, G., So, S., Wang, S.Y., Eppink, B., Chung, Y.M., Shalev, G., Shema, E. et al. (2011) Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell, 41, 529-542.
4. Pirngruber, J., Shchebet, A., Schreiber, L., Shema, E., Minsky, N., Chapman, R.D., Eick, D., Aylon, Y., Oren, M. and Johnsen, S.A. (2009) CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3′-end processing. EMBO Rep., 10, 894-900.
5. Fierz, B., Chatterjee, C., McGinty, R.K., Bar-Dagan, M., Raleigh, D.P. and Muir, T.W. (2011) Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat. Chem. Biol., 7, 113-119.
6. Kim, J., Guermah, M., McGinty, R.K., Lee, J.S., Tang, Z., Milne, T.A., Shilatifard, A., Muir, T.W. and Roeder, R.G. (2009) RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell, 137, 459-471.
7. Smith, E. and Shilatifard, A. (2010) The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol. Cell, 40, 689-701.
8. Shema, E., Tirosh, I., Aylon, Y., Huang, J., Ye, C., Moskovits, N., Raver-Shapira, N., Minsky, N., Pirngruber, J., Tarcic, G. et al. (2008) The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev., 22, 2664-2676.
9. Zhu, B., Zheng, Y., Pham, A.D., Mandal, S.S., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (2005) Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol. Cell, 20, 601-611.
10. Kim, J., Hake, S.B. and Roeder, R.G. (2005) The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Mol. Cell, 20, 759-770.
11. Shema, E., Kim, J., Roeder, R.G. and Oren, M. (2011) RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Mol. Cell, 42, 477-488.
12. Barber, T.D., McManus, K., Yuen, K.W., Reis, M., Parmigiani, G., Shen, D., Barrett, I., Nouhi, Y., Spencer, F., Markowitz, S. et al. (2008) Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl Acad. Sci. USA, 105, 3443-3448.
13. Yart, A., Gstaiger, M., Wirbelauer, C., Pecnik, M., Anastasiou, D., Hess, D. and Krek, W. (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol., 25, 5052-5060.
14. Rozenblatt-Rozen, O., Hughes, C.M., Nannepaga, S.J., Shanmugam, K.S., Copeland, T.D., Guszczynski, T., Resau, J.H. and Meyerson, M. (2005) The parafibromin tumour suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol., 25, 612-620.
15. Jaehning, J.A. (2010) The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim. Biophys. Acta, 1799, 379-388.
16. Chaudhary, K., Deb, S., Moniaux, N., Ponnusamy, M.P. and Batra, S.K. (2007) Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene, 26, 7499-7507.
17. Hahn, M.A. and Marsh, D.J. (2005) Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene, 24, 6241-6248.
18. Tan, M.-H., Morrison, C., Wang, P., Yang, X., Haven, C.J., Zhang, C., Zhao, P., Tretiakova, M.S., Korpi-Hyovalti, E., Burgess, J.R. et al. (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin. Can. Res., 10, 6629-6637.
19. Hahn, M.A. and Marsh, D.J. (2007) Nucleolar localization of parafibromin is mediated by three nucleolar localization signals. FEBS Lett., 581, 5070-5074.
20. Panicker, L.M., Zhang, J.H., Dagur, P.K., Gastinger, M.J. and Simonds, W.F. (2010) Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr. Relat. Cancer, 17, 513-524.
21. Lin, L., Czapiga, M., Nini, L., Zhang, J.H. and Simonds, W.F. (2007) Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function. Mol. Cancer Res., 5, 183-193.
22. Farber, L.J., Kort, E.J., Wang, P., Chen, J. and Teh, B.T. (2010) The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA. Mol. Carcinog., 49, 215-223.
23. Gill, A.J., Clarkson, A., Gimm, O., Keil, J., Dralle, H., Howell, V.M. and Marsh, D.J. (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am. J. Surg. Pathol., 30, 1140-1149.
24. Carpten, J.D., Robbins, C.M., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-WIlson, J., Simonds, W.F., Gillanders, E.M., Kennedy, A.M., Chen, J.D. et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat. Genet., 32, 676-680.
25. Shattuck, T.M., Valimaki, S., Obara, T., Gaz, R.D., Clark, O.H., Shoback, D., Wierman, M.E., Tojo, K., Robbins, C.M., Carpten, J.D. et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N. Engl. J. Med., 349, 1722-1729.
26. Howell, V.M., Haven, C.J., Kahnoski, K., Khoo, S.K., Petillo, D., Chen, J., Fleuren, G.J., Robinson, B.G., Delbridge, L.W., Philips, J. et al. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J. Med. Genet., 40, 657-663.
27. Marsh, D.J., Hahn, M., Howell, V.M. and Gill, A.J. (2007) Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes. Exp. Opin. Med. Diagn., 1, 377-392.
28. Chen, J.D., Morrison, C., Zhang, C., Kahnoski, K., Carpten, J.D. and Teh, B.T. (2003) Hyperparathyroidism-jaw tumour syndrome. J. Intern. Med., 253, 634-642.
29. Marx, S.J. (2000) Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med., 343, 1863-1875.
30. Zhao, J., Yart, A., Frigerio, S., Perren, A., Schraml, P., Weisstanner, C., Stallmach, T., Krek, W. and Moch, H. (2007) Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene, 26, 3440-3449.
31. Selvarajan, S., Sii, L., Lee, A., Yip, G., Bay, B., Tan, M., Teh, B. and Tan, P. (2008) Parafibromin expression in breast cancer: a novel marker for prognostication? J. Clin. Pathol., 61, 64-67.
32. Zheng, H., Takahashi, H., Li, X., Hara, T., Masuda, S., Guan, Y. and Takano, Y. (2008) Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Archiv., 452, 147-155.
33. Zheng, H.C., Wei, Z.L., Xu, X.Y., Nie, X.C., Yang, X., Takahashi, H. and Takano, Y. (2011) Parafibromin expression is an independent prognostic factor for colorectal carcinomas. Hum. Pathol., 42, 1089-1102.
34. Mosimann, C., Hausmann, G. and Basler, K. (2006) Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell, 125, 327-341.
35. Agarwal, S.K., Simonds, W.F. and Marx, S.J. (2008) The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3. Mol. Cancer, 7, 65.
36. Dalgliesh, G.L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C. et al. (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature, 463, 360-363.
37. Nikoloski, G., Langemeijer, S.M., Kuiper, R.P., Knops, R., Massop, M., Tonnissen, E.R., van der Heijden, A., Scheele, T.N., Vandenberghe, P., de Witte, T. et al. (2010) Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet., 42, 665-667.
38. Espinosa, J.M. (2008) Histone H2B ubiquitination: the cancer connection. Genes Dev., 22, 2743-2749.
39. Li, X.S., Trojer, P., Matsumura, T., Treisman, J.E. and Tanese, N. (2010) Mammalian SWI/SNF-a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol. Cell. Biol., 30, 1673-1688.
40. Zhang, F. and Yu, X. (2011) WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. Mol. Cell, 41, 384-397.
41. Pavri, R., Zhu, B., Li, G., Trojer, P., Mandal, S., Shilatifard, A. and Reinberg, D. (2006) Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell, 125, 703-717.
42. Hahn, M.A., McDonnell, J. and Marsh, D.J. (2009) The effect of disease-associated HRPT2 mutations on splicing. J. Endocrinol., 201, 387-396.
43. Howell, V.M., Gill, A., Clarkson, A., Nelson, A.E., Dunne, R., Delbridge, L.W., Robinson, B.G., Teh, B.T., Gimm, O. and Marsh, D.J. (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J. Clin. Endocrinol. Metab., 94, 434-441.